Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans

Anesthesiology

Volumn 108, Issue 2, 2008, Pages 225-232

  Drummond, John C ^a,b   Dao, Andrew V ^b   Roth, David M ^a,b   Cheng, Ching Rong ^a,b   Atwater, Benjamin I ^a,b   Minokadeh, Anushirvan ^a,b   Pasco, Leonardo C ^a   Patel, Piyush M ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; DEXMEDETOMIDINE;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BISPECTRAL INDEX; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CEREBRAL METABOLIC RATE; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPERVENTILATION; JUGULAR BULB VENOUS SATURATION; MALE; METABOLIC RATE; NERVOUS SYSTEM INJURY; NORMAL HUMAN; PRIORITY JOURNAL; SEDATION;

EID: 38549161511     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000299576.00302.4c     Document Type: Article

References (15)

1. Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, Butterworth J: Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg 2002; 95:1052-9
2. Zornow MH, Maze M, Dyck JB, Shafer SL: Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 1993; 13:350-3
3. Zornow MH, Fleischer JE, Scheller MS, Nakakimura K, Drummond JC: Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990; 70:624-30
4. Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA: Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990; 71:125-9
5. Matta BF, Lam AM: The rate of blood withdrawal affects the accuracy of jugular venous bulb: Oxygen saturation measurements. ANESTHESIOLOGY 1997; 86:806-8
6. Schell RM, Cole DJ: Cerebral monitoring: Jugular venous oximetry. Anesth Analg 2000; 90:559-66
7. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. ANESTHESIOLOGY 2000; 93:382-94
8. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699-705
9. Asano Y, Koehler RC, Kawaguchi T, McPherson RW: Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat. Am J Physiol 1997; 272:H2547-56
10. Bekker A, Sturaitis MK: Dexmedetomidine for neurological surgery. Neurosurgery 2005; 57:1-10
11. Cohen Z, Molinatti G, Hamel E: Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 1997; 17:894-904
12. Bishop CC, Powell S, Rutt D, Browse NL: Transcranial Doppler measurement of middle cerebral artery blood flow velocity: A validation study. Stroke 1986; 17:913-5
13. Larsen FS, Olsen KS, Hansen BA, Paulson OB, Knudsen GM: Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994; 25:1985-8
14. Toda N: Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries. J Pharmacol Exp Ther 1983; 226:861-8
15. Ferrari-DiLeo G, Potter LT: Alpha-adrenoreceptors and muscarinic receptors in human pial arteries and microvessels: A receptor binding study. J Cereb Blood Flow Metab 1985; 5:458-64